A-A-54169
31 May 1990
COMMERCIAL ITEM DESCRIPTION
HALOPROGIN TOPICAL SOLUTION, USP
The General Services Administration has authorized the use of this Commercial Item Description as a replacement for Military Specification MIL-H-37247 which is cancelled.
Salient characteristics:
Shall be Haloprogin Topical Solution, USP.
Shall be in accordance with the requirements of the USP.
All ingredients shall be of a pharmaceutical grade.
Shall contain 10 mg per ml of Haloprogin within the
applicable assay limits for the solution.
Workmanship. The solution shall be free from defects which detract from its appearance or impair its serviceability.
Unit. Bottle (BT).
For Size - 1. One commercially available dropper-tip squeeze bottle containing 10 ml, as specified, constitute one unit.
For Size - 2. One commercially available dropper-tip squeeze bottle containing 30 ml, as specified, constitutes one unit.
Contractor certification. The contractor shall certify that the product offered meets the salient characteristics of this description and conforms to the producers’ own drawings, specifications, standards, and quality assurance practices. The Government reserves the right to require proof of such conformance prior to first delivery and thereafter as may be otherwise provided for under the provisions of the contract.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business